Radiation inhibits cell cycle progression and this inhibition includes both an arrest of initiation of DNA synthesis, a G/1 block, and a block in passage through G/2. Arrests in cell cycle progression at the G/1/S and G/2/M interfaces, which occur following DNA damage provide an increased opportunity for repair of radiation damage increasing cell survival. The recent elucidation of the molecular details underlying the regulation of cell cycle progression, especially the transition from G/1 to S phase, suggests that it may be possible to understand mechanistically how G/1 arrest following DNA damage occurs, and also whether modulation of G/1 arrest might change the radiation sensitivity of tumor and normal cells. The p53 gene has a role in the G/1 arrest that follows radiation-induced DNA damage in fibroblasts and human tumor cell lines. Damage of cellular DNA by either radiation or chemical agents is associated with an increase in cellular p53 protein levels, and the arrest of cells in G/1. The RB gene regulates cell proliferation in part by restricting cell cycle progression during G/1. Recognition that RB and p53 both exert important regulatory functions at the G/1/S interface has only emerged recently. Experiments to understand the mechanism by which the G/1 arrest following irradiation is mediated may provide insight into the regulation of G/1 in both tumor and normal cells. We, therefore, propose: 1) to characterize the pattern of expression and activity of known mediators of cell cycle progression at G/1 in irradiated normal and malignant cells in which p53 and RB gene function will be evaluated; and, 2) to identify, isolate, and characterize genes important for the G/1 cell cycle arrest which occurs following exposure to radiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA013525-22
Application #
3748811
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rodriguez, Fausto J; Tihan, Tarik; Lin, Doris et al. (2014) Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol 38:1058-70
Chang, Susan M; Parney, Ian F; Huang, Wei et al. (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-64
Parney, Ian F; Kunwar, Sandeep; McDermott, Michael et al. (2005) Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 102:267-75
Prados, Michael D; Seiferheld, Wendy; Sandler, Howard M et al. (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147-52
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
McKnight, Tracy R; von dem Bussche, Mary H; Vigneron, Daniel B et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802
Hamel, W; Zirkel, D; Mehdorn, H M et al. (2001) (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells. Cancer Gene Ther 8:388-96
Simmons, M L; Lamborn, K R; Takahashi, M et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61:1122-8
Hamel, W; Dazin, P; Israel, M A (1996) Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-81
Hamel, W; Magnelli, L; Chiarugi, V P et al. (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56:2697-702

Showing the most recent 10 out of 14 publications